Grants8 | The most comprehensive grants search on the web

Grant Analysis

Purpose & Target

This grant provides emergency supplemental funding to existing National Institutes of Health (NIH) awardees.
Its core objective is to support research and activities directly responding to a presidentially declared disaster, public health emergency, or other local/regional/national disaster.
This funding is accessed through specific 'Emergency Notices of Special Interest (NOSIs)' published by NIH Institutes/Centers that refer to this mechanism.
Target recipients are organizations already holding an active NIH grant or cooperative agreement.
SECTOR-AGNOSTIC as the original research scope of the parent award can vary widely, but typically involves biomedical research, public health, or health-related fields.
Geographic scope covers both U.S. and non-U.S. entities that hold an existing NIH award.
Key filtering criteria: Must possess an active NIH grant and your proposed work must directly address an officially declared emergency referenced by a specific NOSI.
This is a recurring mechanism, reissued from PA-20-135, and is available until April 19, 2027, but specific application opportunities depend on the release of Emergency NOSIs.

Financial Structure

Budget range and limitations: Application budgets are not limited but must reflect the actual needs of the proposed project and be fully justified.
Eligible costs: Pre-award costs are allowable as described in the NIH Grants Policy Statement (Section 7.9.1 Selected Items of Cost).
Ineligible costs: Not explicitly stated, but generally costs not directly related to the justified emergency response activities.
Matching fund requirements: No cost sharing is required.
Payment schedule and mechanisms: The funding instrument will be the same as the parent award (Grant or Cooperative Agreement). Awards are issued as a Notice of Award (NoA) for supplemental activities, or as a revision to the current year NoA, or included in a future year NoA.
Financial reporting requirements: Progress reports and budgets for the supplement must be included with, but clearly delineated from, the parent award's reporting. This is submitted via the Research Performance Progress Report (RPPR).
Indirect cost policies: NIH will use the institution's current F&A rate (Facilities & Administrative costs) when calculating the award.
Financial guarantees: Not explicitly mentioned, but subject to standard NIH grant terms.

Eligibility Requirements

Organizational Eligibility

Must administer an active NIH parent award (grant or cooperative agreement).
Eligible organization types: Higher Education Institutions (Public/State Controlled, Private), Nonprofits (501(c)(3) and others), For-Profit Organizations (Small Businesses and others), Local Governments (State, County, City/Township, Special District), Indian/Native American Tribal Governments (Federally Recognized and others), Federal Government Agencies, U.S. Territories/Possessions.
Other eligible entities include Independent School Districts, Public Housing Authorities/Indian Housing Authorities, Native American Tribal Organizations (other than Federally recognized tribal governments), Faith-based or Community-based Organizations, and Regional Organizations.
Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible if they meet the parent award requirement.

Individual Eligibility

The Program Director/Principal Investigator (PD/PI) must hold an active grant or cooperative agreement award with NIH.
The PD/PI should work with their organization to develop applications.
For awards with multiple PDs/PIs, any or all may request the revision, submitted by the recipient organization.
Cannot be used to add, delete, or change PDs/PIs on the parent award.

Technical and Registration Requirements

Applicant organizations must complete and maintain active registrations with:
System for Award Management (SAM.gov) and its annual renewal. Foreign organizations need a NATO Commercial and Government Entity (NCAGE) Code.
Unique Entity Identifier (UEI) obtained through SAM.gov.
eRA Commons, with at least one Signing Official (SO) and one Program Director/Principal Investigator (PD/PI) account.
Grants.gov.
All PDs/PIs must have an eRA Commons account, affiliated with the applicant organization.

Exclusion Criteria

Applications not in response to an Emergency Notice of Special Interest (NOSI) that refers to this funding opportunity (PA-24-201) will not be accepted.
Applications that do not comply with application instructions (How to Apply - Application Guide and program-specific instructions) may be delayed or not accepted for review.
Does not require cost sharing.

Application Process

Application Package

Applicants must prepare applications using current forms in accordance with the NIH 'How to Apply - Application Guide'.
The application forms package is accessed through NIH ASSIST, Grants.gov Workspace, or an institutional system-to-system solution.

Content and Submission

All applications must be submitted electronically in response to an Emergency Notice of Special Interest (NOSI) that refers to this NOFO (PA-24-201).
Follow instructions in the 'How to Apply - Application Guide' and any program-specific instructions in the NOSI. Deviations may lead to delays or rejection.
Page limitations for the parent award generally apply, with exceptions or additions specified in the NOSI.
Required forms include: SF424 (R&R) Cover, Project/Performance Site Locations, Other Project Information, Senior/Key Person Profile, Budget, Subaward Budget, PHS 398 Cover Page Supplement, PHS 398 Research Plan, PHS Human Subjects and Clinical Trials Information (if applicable).
A Data Management and Sharing (DMS) Plan must be addressed if applicable to the parent award and the competitive revision changes its approach. An updated DMS Plan must be provided prior to award if required.
Limited Appendix materials are allowed.
Foreign Organizations must follow NIH Grants Policy Statement policies and procedures for foreign organizations.

Deadlines and Submission

Application Due Date: The specific application due date will be provided in the Emergency Notice of Special Interest (NOSI). The overall expiration date for this funding opportunity (PA-24-201) is 2027-04-19.
Applicants are encouraged to apply early to allow time for corrections.
If a submission date falls on a weekend or Federal holiday, the deadline is automatically extended to the next business day.
Applicants are responsible for viewing their electronic application in eRA Commons to ensure successful submission.

Post-Award Requirements

Award Notices: A formal Notice of Award (NoA) is provided. Costs incurred before NoA are at recipient's risk.
ClinicalTrials.gov: If the award includes clinical trials, the responsible party must register and submit results information. NIH expects registration of all trials.
IRB/IEC Approval: Grantee institutions must ensure all protocols are reviewed by their Institutional Review Board (IRB) or Independent Ethics Committee (IEC).
Data and Safety Monitoring: Required for human biomedical and behavioral intervention studies (clinical trials).
IND/IDE Requirements: Clinical research involving investigational therapeutics/vaccines/devices must be performed under an FDA investigational new drug (IND) or investigational device exemption (IDE).

Evaluation Criteria

Overall Impact

Reviewers will assess the likelihood of the project to have a sustained, powerful influence on the research field(s) involved.

Appropriateness for Emergency

For emergency applications, NIH staff will consider how appropriate the proposed application is in response to the specific Emergency Notice of Special Interest (NOSI).
Responsiveness to the immediate need to help address a specific public health crisis in a timely manner, as per the associated NOSI, will be evaluated.

Budget and Period of Support

Reviewers will assess whether the proposed budget and requested period of support are fully justified and reasonable in relation to the proposed research activities.

Specific Review Considerations (if applicable to the proposed project)

Protections for Human Subjects: Evaluation of justification for involvement, proposed protections against research risk, potential benefits, importance of knowledge gained, and data/safety monitoring for clinical trials. For exempt research, justification for exemption, human subjects involvement/characteristics, and material sources.
Inclusion of Women, Racial and Ethnic Minorities, and Individuals Across the Lifespan: Evaluation of plans for inclusion (or exclusion) based on sex, race, ethnicity, and age, ensuring scientific justification.
Vertebrate Animals: Assessment of procedures (species, strains, ages, sex, numbers), justification for species choice and why non-animal models cannot be used, and interventions to limit discomfort/distress/pain/injury.
Biohazards: Assessment of potential hazards to personnel/environment and adequacy of proposed protections.

Compliance & Special Requirements

Regulatory Compliance

All NIH awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.
Federal Regulations: Awards are made under Sections 301 and 405 of the Public Health Service Act (42 USC 241 and 284) and Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.
Prohibition on Certain Telecommunications: Compliance with prohibitions on certain telecommunications and video surveillance services/equipment.

Data Protection and Sharing

Consistent with the 2023 NIH Policy for Data Management and Sharing, recipients must adhere to Data Management and Sharing requirements if applicable to the award. An approved DMS Plan must be implemented.

Ethical and Civil Rights Standards

Civil Rights Compliance: Recipients of federal financial assistance from HHS must comply with federal civil rights laws prohibiting discrimination based on race, color, national origin, disability, age, religion, conscience, and sex. This includes ensuring accessibility for persons with limited English proficiency and individuals with disabilities.
Sexual Harassment: Health and education programs must be administered in an environment free of sexual harassment.
Religious Nondiscrimination/Conscience Protection: Programs must not discriminate against persons or entities based on their consciences, religious beliefs, or moral convictions.

Reporting Compliance

Federal Funding Accountability and Transparency Act (FFATA): Recipients must report information about first-tier subawards and executive compensation via the Federal Subaward Reporting System (FSRS.gov).
Integrity and Performance Reporting: Recipients with cumulative Federal awards over $10,000,000 must report and maintain currency of information in SAM.gov regarding civil, criminal, and administrative proceedings.
Special Reporting: Any special reporting requirements specific to the public health emergency will be specified in the terms and conditions of award.

Other Special Considerations

This funding is explicitly for emergency situations (presidentially declared disaster, public health emergency, etc.).
This mechanism is a competitive revision to an existing active NIH award; it is not for new, standalone projects.
The scientific scope of the revision must align with the emergency and be consistent with the parent award's research area.
Substantial Federal scientific or programmatic involvement may occur if the funding instrument is a Cooperative Agreement.
Applicant organizations may submit more than one application, provided each is sufficiently distinct from others currently under consideration.

Grant Details